Companies Currently Raising

Industry key:
 
Click on a Company’s name for contact information.

20/20 GeneSystems is the #2 leader in the U.S. is the fast-growing market for multi-cancer early detection(MCED)blood tests.

An innovative oncology-focused startup company, led by proven drug hunter, that is poised to transform the lives of cancer patients with high unmet needs.

AiM is developing a compact neurosurgery robot that improves Parkinson's implant precision with real-time MRI guidance.

Alphyn’s 1st drug for the $118B eczema market clinical results are superior to competitors pointing to “drug of choice”.

End-to-end management of sterilization processes in healthcare to improve patient safety, efficiency and sustainability.

Revolutionizing pain management after wisdom tooth extraction – 1 dose, 1 novel formulation, 3 medications, 0 opioids.

Leading the revolution to eliminate solid tumors.

Axcess Instruments brings a 4k, fully digital imaging device for minimally invasive surgery.

BraveHeart has created a breakthrough in at-home, AI driven Congestive Heart Failure monitoring technology.

A medical device company that was founded to solve an unsafe and complicated problem of filtering. CarrTech has built and patented and submitted to the FDA the first and only integrated all in one package, one- needle, one-step filter pioneering a safer, more efficient, and cost-effective way to preparing ampoule-based medications.

ChromaTan has developed BioRMB™ the first-ever, continuous column-free, single-use, and steady-state chromatography platform, based on the Real Moving Bed principle that provides significant improvements in recovery, productivity, and product purity.

We put medicine into clothing; controlled delivery of active ingredients (medications and OTC) through everyday apparel.

CraniUS is revolutionizing the treatment of chronic brain diseases by developing NeuroPass™, the first fully implantable, skull-embedded drug delivery system.

The world’s most compact and scalable optical filters, 20x the value of gold, made 10x more economically than competition, with 37 patents.

General Biologics, Inc. is developing a therapeutic protein to treat hypoxic disorders, such as COPD, and cystic fibrosis.

A patented and revolutionary, 3-in-1 formula medical food to help treat depression naturally and sold directly to consumers.

Stops patients from bleeding to death - bleeding from injuries like car crashes, postpartum hemorrhage, or battlefield injuries. 

MediMergent is an AI-driven, patient-centric, digital healthcare company capturing Real-World Evidence (RWE), directly from the Voice of the Patient.

Myoptechs™ is an ophthalmic medical device company developing a novel soft contact lens specifically designed to slow the progression of myopia while providing exceptionally clear vision.

NeuroEM's first-of-its-kind device offers a safe, effective, and non-invasive approach to treating neurodegenerative diseases, including Alzheimer's, and protecting brain health throughout the aging process.

OSSA Oral Care, the first Flouride-Free Solution to Tackle Gingivitis Naturally.

Ovala is medical device company focused on women’s health and stress urinary incontinence with an over-the-counter FDA approved solution. 

RoadDoc is building a decentralized healthcare ecosystem to deliver care to chronically underserved and hard-to-reach populations across the care continuum.

Tympanogen develops ear, nose, and throat (ENT) devices that simplify existing procedures and improve treatment outcomes using our proprietary gel technology.

Clinical Stage Non violent Chemotherapy Company: A new paradigm in anti cancer drug discovery.

A paradigm-shifting biopharmaceutical contract development and manufacturing organization (CDMO) poised to benefit from the proposed BIOSECURE Act.